Development of pulmonary intravascular macrophage function in newborn lambs.
We sought to determine whether pulmonary intravascular macrophages are involved in pulmonary vascular sensitivity to intravenously injected particles in sheep. We estimated that newborn lambs have few of these macrophages at birth but develop a 10-fold greater density within 2 wk. Awake, chronically instrumented newborn lambs showed no change in pulmonary vascular driving pressure (pulmonary arterial minus left atrial pressure) after injection of either liposomes [2 +/- 3 (SD) cmH2O; n = 5] or Monastral blue particles (3 +/- 2 cmH2O; n = 6) and showed no net pulmonary production of thromboxane B2, the stable metabolite of the vasoconstrictor thromboxane A2. In contrast, five of those lambs 2 wk later showed both an increase in pulmonary vascular driving pressure after injection of liposomes and Monastral blue (20 +/- 16 and 25 +/- 15 cmH2O, respectively; P < 0.05) and net pulmonary production of thromboxane B2 (171 +/- 103 and 429 +/- 419 pg/ml plasma, respectively; P < 0.05). Older lambs (n = 5) had higher pulmonary uptakes than newborn lambs (n = 6) of radioactive liposomes (47 +/- 13 vs. 12 +/- 10%; P < 0.01) and Monastral blue (53 +/- 6 vs. 21 +/- 10%; P < 0.05). We conclude that pulmonary intravascular macrophages are responsible for the sensitivity of sheep to intravenous foreign particles and are essential for a cascade of processes leading to microvascular injury.
Longworth
K E
KE
Cardiovascular Research Institute, University of California, San Francisco 94143.
Westgate
A M
AM
Grady
M K
MK
Westcott
J Y
JY
Staub
N C
NC
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000758:Anesthesia; D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001784:Blood Gas Analysis; D001794:Blood Pressure / Q000502:physiology; D002302:Cardiac Output / Q000187:drug effects; D006439:Hemodynamics / Q000502:physiology; D006651:Histocytochemistry; D007211:Indoles; D008081:Liposomes; D008168:Lung / Q000254:growth & development / Q000502:physiology; D008264:Macrophages / Q000502:physiology*; D009942:Organometallic Compounds; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D011652:Pulmonary Circulation / Q000502:physiology; D012756:Sheep; D013929:Thromboxane B2 / Q000096:biosynthesis; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D007211:Indoles; D008081:Liposomes; D009942:Organometallic Compounds; D011450:Prostaglandin Endoperoxides, Synthetic; D014662:Vasoconstrictor Agents; C015445:copper phthalocyanine; D013929:Thromboxane B2; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid